Searching in NIH · Search everything

Clear filters

4 changes Priority review, last 7 days

Favicon for www.regulations.gov

NIH Terminates Minority Biomedical Research Support Program

The Department of Health and Human Services (HHS), through the National Institutes of Health (NIH), is repealing the regulation for the Minority Biomedical Research Support (MBRS) program. This action is effective September 25, 2025, and aligns with recent Supreme Court decisions and executive orders concerning discrimination and DEI programs.

Priority review Rule Healthcare
2d ago NIH Policy Notices
Favicon for grants.nih.gov

NIH Extends Common Forms Timeline for Biographical Sketch and Other Support

The National Institutes of Health (NIH) has extended the leniency period for implementing Common Forms for Biographical Sketch and Current and Pending (Other) Support until May 2026. This notice adjusts the original January 25, 2026 deadline to allow the extramural community more time for adoption and compliance.

Priority review Notice Education
2d ago NIH Policy Notices
Favicon for grants.nih.gov

NIH Reminder: IRB Approval Certification Required Before Award

The National Institutes of Health (NIH) issued a notice reminding the extramural research community that certification of Institutional Review Board (IRB) approval is required before award for nonexempt human subjects research. Funds cannot be used for such research without this certification, which must be the date of final IRB approval, not pending or expired.

Priority review Notice Education
Favicon for grants.nih.gov

NIDA Funding Opportunity PAR-24-298 Expires Early

The National Institute on Drug Abuse (NIDA) has issued a notice announcing the immediate early expiration of the funding opportunity PAR-24-298, "Mechanism for Time-Sensitive Substance Use Research (R21 Clinical Trial Optional)". No further applications will be accepted under this announcement.

Priority review Notice Education

Get alerts for ""

We'll email you when new changes match this search.

Free. Unsubscribe anytime.